PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

WHI reports $37.1B economic return on combined hormone therapy clinical trial

Researchers at Fred Hutchinson Cancer Research Center demonstrate high-value investment of public funds has substantial economic return

2014-05-06
(Press-News.org) SEATTLE – Economic findings were released today on the Women's Health Initiative (WHI), estrogen plus progestin (E+P) trial. The WHI is one of the largest National Institutes of Health-funded studies ever conducted on women. Housed at the Fred Hutchinson Cancer Research Center in Seattle, it is a 15-year, multimillion-dollar study established in 1991, involving more than 160,000 women nationwide, including some 3,500 in Washington.

The overall economic return from the WHI E+P trial indicates that changes in practice stemming from the trial provided a net economic return of $37.1 billion over the 10-year period since the main findings were published, providing a return of approximately $140 on every dollar invested in the trial.

The findings, published today in the Annals of Internal Medicine, are the result of collaboration between WHI investigators and faculty at the Hutchinson Institute for Cancer Outcomes Research. The researchers created a disease simulation model to evaluate clinical and economic outcomes for combined hormone therapy (cHT) eligible women since the initial publication of the E+P trial results in 2003.

The study first estimated clinical outcomes for women taking cHT following the study versus a counterfactual scenario where the E+P trial was not conducted and cHT use persisted at historical (pre-2003) trends. Based on the projected clinical outcomes, the study then calculated the net economic return of the trial, less the trial cost.

During the 10 years following publication of WHI E+P findings, the investigators estimated that 4.3 million fewer women used cHT. As a result there were 126,000 fewer breast cancer cases, 76,000 fewer cardiovascular events, 263,000 more osteoporotic fractures, and 15,000 more colorectal cancer cases compared to the no trial scenario. The observed reduction in cHT prescribing saved $49.5 billion in direct medical care costs. In addition, the net health yield for women in the U.S. was approximately 145,000 more quality-adjusted life years than would have occurred in absence of the trial. Assuming that 75% of the change in cHT prescribing can be directly attributed to the WHI, and subtracting the cost of the study itself ($260 million) the net economic return of WHI E+P trial was $37.1 billion.

"The WHI trial is often discussed as having a major impact on post-menopausal combined hormone therapy use, but I'm not aware of any other studies that have projected how many fewer women used combined hormone therapy as a result of the trial," said Joshua Roth, Ph.D., MHA, Hutchinson Institute for Cancer Outcomes Research, and lead author of the study. "It really brings the point home when you crunch the numbers, to see that millions of U.S. women likely stopped or never used combined hormone therapy based on the trial's findings, and that the change in use resulted in important reductions in disease incidence and associated medical spending."

Of the $37.1 billion in net economic return attributable to the WHI E+P trial, $26.4 billion was attributable to medical expenditure savings. These savings were driven by 25 million fewer person-years of cHT use, as well as cost savings from avoided diseases. The remaining $10.7 billion represents the value of additional quality-adjusted life expectancy resulting from lower incidence of breast cancer, cardiovascular disease, and venous thromboembolism.

"The motivation for the first WHI trial was to see if we could prevent heart disease, the number one killer of women. That's why we did it - the economics never occurred to me," said Garnet Anderson, Ph.D., lead Women's Health Initiative investigator and director of Fred Hutchinson Cancer Research Center's Public Health Sciences Division. "What these findings underscore is the significant role clinical trials play in science and the importance of continuing to find ways to strategically invest public research funds to maximize value to society."

The WHI E+P clinical trial was funded by the National Heart, Lung, and Blood Institute (NHLBI), and its success was realized by dedicated study participants who contributed their time to help answer important research questions. Today's report on the $37.1 billion economic return of its E+P trial suggests that large public research investments can yield considerable clinical and economic value when targeted to address research questions with high clinical relevance and public health impact.

"It is important to consider the potential value of studies when making decisions about how to invest limited public research dollars," said Scott Ramsey, M.D., Ph.D., Director of Hutchinson Institute for Cancer Outcome Research. "Many stakeholders have talked about the high cost of the WHI estrogen plus progestin trial, but few have considered the potential value of the trial. These findings show that the trial was a high-value use of public funds with a substantial return on investment."

INFORMATION: The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, and the U.S. Department of Health and Human Services.

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch's pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation's first and largest cancer prevention research program, as well as the clinical coordinating center of the Women's Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit http://www.fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.

Contact Michael Nank
Media Relations Manager
206-667-2210 (O)
206-465-6338 (C)
mnank@fredhutch.org

Rhonda Curry
Director of Communications
206-667-1455 (O)
206-240-6011 (C)
rcurry@fredhutch.org


ELSE PRESS RELEASES FROM THIS DATE:

Novel antioxidant makes old arteries seem young again, CU-Boulder study finds

2014-05-06
An antioxidant that targets specific cell structures—mitochondria—may be able to reverse some of the negative effects of aging on arteries, reducing the risk of heart disease, according to a new study by the University of Colorado Boulder. When the research team gave old mice—the equivalent of 70- to 80-year-old humans—water containing an antioxidant known as MitoQ for four weeks, their arteries functioned as well as the arteries of mice with an equivalent human age of just 25 to 35 years. The researchers believe that MitoQ affects the endothelium, a thin layer of cells ...

Cataract surgery decreases risk of falls in older patients

2014-05-06
Orlando, Fla. — New research finds that cataract surgery dramatically decreases the number of falls individuals suffer due to poor vision. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla. In a study of more than 400 Vietnamese patients who were 50-plus years old with cataracts in both eyes, the number of falls patients suffered before and after cataract surgery was monitored. Researchers found a 78% decrease in the risk of falls the year after patients had cataract ...

Simulated model of eye's 3D structure facilitates stem cells transplant

2014-05-06
Orlando, Fla. — Scientists have developed a model that mimics the complex structure of the cornea to enable the transplant of healthy corneal stem cells. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando Fla. Used to restore sight, corneal stem cells live in a specific physical environment. Transplanting these stem cells requires accurate mimicry of their natural surroundings during transport. In this work, vision scientists have recreated the 3D architecture where corneal ...

Astronomers harness the galaxy's biggest telescope

Astronomers harness the galaxys biggest telescope
2014-05-06
An international team of astronomers has made a measurement of a distant neutron star that is one million times more precise than the previous world's best. The researchers were able to use the interstellar medium, the 'empty' space between stars and galaxies that is made up of sparsely spread charged particles, as a giant lens to magnify and look closely at the radio wave emission from a small rotating neutron star. This technique yielded the highest resolution measurement ever achieved, equivalent to being able to see the double-helix structure of our genes from the ...

A novel transgenic mouse model of Chinese Charcot-Marie-Tooth disease type 2L

A novel transgenic mouse model of Chinese Charcot-Marie-Tooth disease type 2L
2014-05-06
Dr. Ruxu Zhang and colleagues from Third Xiangya Hospital, Central South University in China previously found that the K141N mutation in heat shock protein B8 (HSPB8) was responsible for Charcot-Marie-Tooth disease type 2L in a large Chinese family. Therefore, they generated a transgenic mouse model bearing the K141N mutation in the human HSPB8 gene, and to determine whether this K141NHSPB8 transgenic mouse model would manifest the clinical phenotype of Charcot-Marie-Tooth disease type 2L, and consequently be suitable for use in studies of disease pathogenesis. The K141NHSPB8 ...

Regulatory effects of glial cells on retinal synaptic plasticity

Regulatory effects of glial cells on retinal synaptic plasticity
2014-05-06
Different types of retinal damage could induce plastic changes of retinal synapses, which might precede the serious damage of neuron soma. These morphological and functional changes to synapses after retinal injury could explain why many intervention measures protected neurons from death but failed to fully recover the damaged visual function. Therefore, it is necessary to investigate both the protection of synapses as well as protecting neurons from death. Dr. Lihong Zhou and co-workers from Central South University in China suggested that retinal glial cell activation ...

The Pael-R gene does not mediate the changes in rotenone-induced PD model cells

The Pael-R gene does not mediate the changes in rotenone-induced PD model cells
2014-05-06
Currently, the pathogenesis of Parkinson's disease is not entirely clear, but it has been generally considered to be the result of interactions among various genetic and environmental factors. Ting Zou and coworkers from Second Xiangya Hospital, Central South University in China previously found that Parkin mutation causes Parkin-associated endothelin receptor-like receptor (Pael-R) protein deposition, and the associated cytotoxicity leads to dopaminergic neuronal apoptosis. These researchers speculated that the Pael-R gene is possibly involved in the action of rotenone ...

AMPK and inflammatory mediators are involved in postoperative cognitive dysfunction

AMPK and inflammatory mediators are involved in postoperative cognitive dysfunction
2014-05-06
Postoperative cognitive dysfunction is associated with neuronal apoptosis, which may result from post-surgery inflammation, the phosphorylation of tau protein and the accumulation of amyloid in aged people. 5′adenosine monophosphate-activated protein kinase (AMPK) can be involved in anti-inflammation, neuronal repair and anti-inflammation of the body through different downstream proteins and pathways. In addition, the activation of AMPK regulates tau protein phosphorylation and reduces amyloidogenesis in neurons. Yanlin Bi and co-workers from the Affiliated Qianfoshan ...

Danish social workers have become the moral agents of the state

2014-05-06
"We are turning the professional social workers into moral agents. This development recalls a time before the welfare state, when we had poor relief and when the extent to which the state could help you depended on your own dignity." This is the assertion by Marie Østergaard Møller, who is associate professor at the Department of Political Science and Government, Aarhus University regarding the labour market policy that has been carried out in Denmark since the 1990s. More specifically, since 1994 the opportunities for citizens to get relief from the state have been reduced. ...

Hotspots of climate change impacts in Africa: Making sense of uncertainties

2014-05-06
Overlapping impacts of climate change such as drought or flooding, declining crop yields or ecosystem damages create hotspots of risk in specific parts of Africa. These are for the first time identified in a study now published by the Potsdam Institute for Climate Impact Research. The uncertainties in assessing the impacts do not necessarily hamper but can inform development strategies, according to the scientists. Likelihood and potential severity of impacts can be weighed to decide on suitable adaptation measures. "We found three regions to be amongst those most at ...

LAST 30 PRESS RELEASES:

Pink skies

Monkeys are world’s best yodellers - new research

Key differences between visual- and memory-led Alzheimer’s discovered

% weight loss targets in obesity management – is this the wrong objective?

An app can change how you see yourself at work

NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals

New research shows that propaganda is on the rise in China

Even the richest Americans face shorter lifespans than their European counterparts, study finds

Novel genes linked to rare childhood diarrhea

New computer model reveals how Bronze Age Scandinavians could have crossed the sea

Novel point-of-care technology delivers accurate HIV results in minutes

Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others

Study finds nearly five-fold increase in hospitalizations for common cause of stroke

Study reveals how alcohol abuse damages cognition

Medicinal cannabis is linked to long-term benefits in health-related quality of life

Microplastics detected in cat placentas and fetuses during early pregnancy

Ancient amphibians as big as alligators died in mass mortality event in Triassic Wyoming

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

Alcohol makes male flies sexy

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Study links teen girls’ screen time to sleep disruptions and depression

Scientists unveil starfish-inspired wearable tech for heart monitoring

Footprints reveal prehistoric Scottish lagoons were stomping grounds for giant Jurassic dinosaurs

AI effectively predicts dementia risk in American Indian/Alaska Native elders

First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes

Existing international law can help secure peace and security in outer space, study shows

Pinning down the process of West Nile virus transmission

UTA-backed research tackles health challenges across ages

In pancreatic cancer, a race against time

Targeting FGFR2 may prevent or delay some KRAS-mutated pancreatic cancers

[Press-News.org] WHI reports $37.1B economic return on combined hormone therapy clinical trial
Researchers at Fred Hutchinson Cancer Research Center demonstrate high-value investment of public funds has substantial economic return